These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 1589052
21. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. Bailey RR. N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556 [Abstract] [Full Text] [Related]
22. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Geary DF, Farine M, Thorner P, Baumal R. Clin Nephrol; 1984 Sep 26; 22(3):109-13. PubMed ID: 6488594 [Abstract] [Full Text] [Related]
23. [Lipoid nephrosis in childhood]. Niaudet P. Rev Prat; 2003 Nov 30; 53(18):2027-32. PubMed ID: 15008217 [Abstract] [Full Text] [Related]
24. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period]. Forese S, Tamborino G, Genova R. Minerva Pediatr; 1977 Mar 10; 29(8):547-50. PubMed ID: 865435 [No Abstract] [Full Text] [Related]
25. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children. Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA. Pediatr Nephrol; 2002 May 10; 17(5):355-8. PubMed ID: 12042893 [Abstract] [Full Text] [Related]
26. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients]. Pruna A, Barka A, Nochy D, Hauet T, Boulanger H, Landais P. Nephrologie; 1997 May 10; 18(3):95-101. PubMed ID: 9297136 [Abstract] [Full Text] [Related]
27. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome. Pennisi AJ, Grushkin CM, Lieberman E. Pediatrics; 1976 Jun 10; 57(6):948-51. PubMed ID: 934751 [Abstract] [Full Text] [Related]
28. Natural history and response to treatment of minimal change nephrotic syndrome. Prabhakar KS, Prakash KC, Mani MK. J Assoc Physicians India; 1993 May 10; 41(5):263-5. PubMed ID: 8300454 [Abstract] [Full Text] [Related]
29. Pefloxacin in steroid dependent and resistant idiopathic nephrotic syndrome. Sharma RK, Sahu KM, Gulati S, Gupta A. J Nephrol; 2000 May 10; 13(4):271-4. PubMed ID: 10946806 [Abstract] [Full Text] [Related]
30. Cyclophosphamide therapy in the nephrotic syndrome in childhood. Moncrieff MW, White RH, Oggs CS, Cameron JS. Br Med J; 1969 Mar 15; 1(5645):666-71. PubMed ID: 5774315 [Abstract] [Full Text] [Related]
31. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. Cade R, Mars D, Privette M, Thompson R, Croker B, Peterson J, Campbell K. Arch Intern Med; 1986 Apr 15; 146(4):737-41. PubMed ID: 3963956 [Abstract] [Full Text] [Related]
32. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients]. Caletti MG, Gallo G, Zumino D, Díaz MA, Vitacco M. Bol Med Hosp Infant Mex; 1981 Apr 15; 38(3):457-72. PubMed ID: 7271977 [Abstract] [Full Text] [Related]
33. Cyclosporine utilization in idiopathic nephrotic syndrome in children. Saeed B, Ossman MI, Sheriff S. Saudi J Kidney Dis Transpl; 2006 Dec 15; 17(4):497-502. PubMed ID: 17186683 [Abstract] [Full Text] [Related]
34. Nephrotic syndrome in Hodgkins disease. Walker F, O'Neill S, Carmody M, O'Dwyer WF. Int J Pediatr Nephrol; 1983 Mar 15; 4(1):39-41. PubMed ID: 6853040 [Abstract] [Full Text] [Related]
35. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions. Tejani A, Phadke K, Nicastri A, Adamson O, Chen CK, Trachtman H, Tejani C. Nephron; 1985 Mar 15; 41(2):170-3. PubMed ID: 4047274 [Abstract] [Full Text] [Related]
36. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Haws RM, Baum M. Pediatrics; 1993 Jun 15; 91(6):1142-6. PubMed ID: 8502517 [Abstract] [Full Text] [Related]
37. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Cammas B, Harambat J, Bertholet-Thomas A, Bouissou F, Morin D, Guigonis V, Bendeddouche S, Afroukh-Hacini N, Cochat P, Llanas B, Decramer S, Ranchin B. Nephrol Dial Transplant; 2011 Jan 15; 26(1):178-84. PubMed ID: 20610527 [Abstract] [Full Text] [Related]
38. [Ifosfamide in the treatment of nephrotic syndrome (author's transl)]. Gekle D, Daigeler C. Klin Padiatr; 1977 Sep 15; 189(5):370-5. PubMed ID: 562447 [Abstract] [Full Text] [Related]
39. Treatment aspects of primary nephrotic syndrome in adults. Rasić S, Uncanin S, Dzemidzić J, Aganović K, Srna A, Rasić I. Bosn J Basic Med Sci; 2006 May 15; 6(2):16-20. PubMed ID: 16879107 [Abstract] [Full Text] [Related]
40. Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease. Haddad M, Kale A, Butani L. BMC Nephrol; 2021 Nov 29; 22(1):395. PubMed ID: 34839817 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]